The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.
- Published In:
- BMJ (Clinical research ed.), 388, e082583 (2025)
- Authors:
- Wu, Jianfeng(2), Pei, Fei, Zhou, Lixin, Li, Weiqin, Sun, Renhua, Li, Yimin, Wang, Zheng, He, Zhijie, Zhang, Xiaofei, Jin, Xiaodong, Long, Yun, Cui, Wei, Wang, Chunting, Chen, Erzhen, Zeng, Jun, Yan, Jing, Lin, Qinhan, Zhou, Feihu, Huang, Lei, Shang, You, Duan, Meili, Zheng, Wei, Zhu, Duming, Kou, Qiuye, Zhang, Shihong, Liu, Yin, Yao, Chen, Shang, Meixia, Peng, Sui, Zhou, Qian, Cheng, Kar Keung, Guan, Xiangdong
- Database ID:
- RPEP-14202
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14202APA
Wu, Jianfeng; Pei, Fei; Zhou, Lixin; Li, Weiqin; Sun, Renhua; Li, Yimin; Wang, Zheng; He, Zhijie; Zhang, Xiaofei; Jin, Xiaodong; Long, Yun; Cui, Wei; Wang, Chunting; Chen, Erzhen; Zeng, Jun; Yan, Jing; Lin, Qinhan; Zhou, Feihu; Huang, Lei; Shang, You; Duan, Meili; Zheng, Wei; Zhu, Duming; Kou, Qiuye; Zhang, Shihong; Liu, Yin; Yao, Chen; Shang, Meixia; Peng, Sui; Zhou, Qian; Cheng, Kar Keung; Guan, Xiangdong. (2025). The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.. BMJ (Clinical research ed.), 388, e082583. https://doi.org/10.1136/bmj-2024-082583
MLA
Wu, Jianfeng, et al. "The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.." BMJ (Clinical research ed.), 2025. https://doi.org/10.1136/bmj-2024-082583
RethinkPeptides
RethinkPeptides Research Database. "The efficacy and safety of thymosin α1 for sepsis (TESTS): m..." RPEP-14202. Retrieved from https://rethinkpeptides.com/research/wu-2025-the-efficacy-and-safety
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.